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Abstract 
The present study reports construction of wound dressing materials from degradable 
natural polymers such as hydroxy derivatives of carboxylic acids (PHAs) and 3-
hydroxybutyrate/4-hydroxybutyrate [P(3HB/4HB)] as copolymer. The developed polymer films 
and electrospun membranes were evaluated for its wound healing properties with Grafts – elastic 
nonwoven membranes carrying fibroblast cells derived from adipose tissue multipotent 
mesenchymal stem cells. The efficacy of nonwoven membranes of P(3HB/4HB) carrying the 
culture of allogenic fibroblasts was assessed against model skin defects in Wistar rats. The 
morphological, histological and molecular studies revealed the presence of fibroblasts on 
dressing materials which facilitated wound healing, vascularization and regeneration. Further it 
was also observed that cells secreted extracellular matrix proteins which formed a layer on the 
surface of membranes and promoted the migration of epidermal cells from the neighboring 
tissues surrounding the wound. The wounds under the P(3HB/4HB) membrane carrying cells 
healed 1.4 times faster than the wounds under the cell-free membrane and 3.5 times faster than 
the wounds healing under the eschar (control).The complete wound healing process was 
achieved at Day 14. Thus the study highlights the importance of nonwoven membranes 
developed from degradable P(3HB/4HB) polymers in reducing inflammation, enhancing 
angiogenic properties of skin and facilitating better wound healing process. 
 
Introduction 
The need for novel materials in effective regeneration of injured skin is one of the serious 
concerns in reconstructive medicine. Management of skin injuries owing to burns, traumas, 
surgical interventions is carried out with several surgical and therapeutic devices which heal skin 
defects. These devices are developed using different materials and drugs. The principle and 
methods of replacing the integrity of skin is measured by various factors like depth and severity 
of the injury, phase of the wound healing process, wound location, degree of microbial invasion, 
health conditions of patient and drugs taken by the patient. The basic principle of wound therapy 
relies on debridement and optimal conditions for wound healing. The ideal wound dressing must 
fulfill normal functions of healthy skin which includes antimicrobial potential, promote moist 
wound environment, permit gaseous exchange, provide mechanical protection and be sufficiently 
elastic to fit the wound shape. 
The fundamental studies underpinning cell biology coupled with key clinical landmarks 
led to invention of novel biomaterials which paved their important roles in tissue-engineering of 
skin which envisioned better understanding of skin biology [1]. Studies also revealed three 
important factors in development of tissue-engineered materials including the safety of the 
patient, clinical efficacy and convenience of usage. Perusal of scientific studies have reported 
considerable progress in development of tissue engineered skin for both clinical and 
experimental medicine [1-3]. The composition tissue engineered skin includes the culture of 
epidermal cells and biomaterials with cultured cells for replacing damaged epidermis or deeper 
skin layers. Initially, during development of tissue engineered skin, it is necessary to study the 
properties of the biomaterial being used and determine its function in defect repair [4]. Earlier 
suspensions of cell cultures (fibroblasts, keratinocytes) were used to treat skin wounds. However, 
administration of cell suspensions is not sufficiently effective. Later studies revealed that the 
application of cells pre-cultured on the scaffold was more effective than using cell suspensions 
[5]. Thus, in recent decade there has been tremendous interest towards using tissue-engineered 
constructs: scaffolds carrying cells and drugs and bioactive compounds [2, 6-9]. Tissue-
engineered skin has been successfully used to treat various diseases and skin defects such as 
vitiligo, melanoma, psoriasis, and blistering disorders [1]. 
Significant progress has been achieved since 25 years at creating tissue-engineered skin, 
yet there is a need for advancement such as providing a barrier layer of renewable keratinocytes 
(the cells that form the upper barrier layer of our skin), which is securely attached to the 
underlying dermis, is well vascularized and provides an elastic structural support for skin [2]. 
Recent studies demonstrate the role of biomaterials used to create tissue-engineered skin. One of 
the major challenges is to choose an ideal material for constructing grafts, which can be shaped 
as 2D and 3D constructs. Wound dressings described in the literature include tissue-engineered 
systems of keratinocytes or fibroblasts seeded onto scaffolds of various materials such as 
composites of polylactide/glycolide [10], polyethylene and silicon, collagen and 
glucosaminoglycan [11, 12]. 
These models can be used in clinical investigation of various skin diseases [13]. The 
effective production and cultivation of keratinocytes in laboratory provided a basis for the 
clinical use [14]. One of the main factors determining successful skin regeneration is the 
adequate scaffold. Among the most promising cell scaffolds, nonwoven polymer 
membranesproduced by electrospinning demonstrate better advantages, as they have similar 
structure to that of collagen fibers of living tissues [2, 3, 14-17]. Electrospinning can be used to 
produce 3D open porous structures and it is also possible to electrospin natural materials such as 
collagen and chitosan or synthetic materials such as poly-L-lactide (PLLA), polycaprolactone 
(PCL) and polyglycolic acid (PGA) [18]. 
The design and construction of tissue engineering can be achieved with various synthetic 
and natural polymers whose efficacy is tested for their potential use as carriers of cells for wound 
healing. Construction of atraumatic wound dressings is among the most promising lines of 
research. Non-adherent dressings are constructed by using hydrophobic polymer material or by 
forming a hydrophobic wound contact layer. But some of the major constraints of many wound 
dressings is that they stick to the wound surface, injuring the regenerating tissues and causing 
pain. The adhesion of the dressing materials to the wound surface may be caused by various 
reasons, the most frequent of which is “gluing” of the dressing to the wound surface. The “glue” 
is the exudate, which dries and forms an eschar. As the hydrophilicity of the polymer material 
constituting the dressing is increased, it adheres to the wound surface more firmly. During the 
granulation phase, the adhesion of the wound dressing is associated with the growth of the 
granulation tissue into the pores of the dressing material. This problem is usually resolved by 
fabricating wound dressings from hydrophobic polymer materials or by using hydrophobic 
synthetic polymer to make the wound-facing surface of the dressing. However, such dressings do 
not adhere properly to the wound surface and their absorption rate is low, causing exudate 
accumulation on the wound. Atraumatic absorptive wound dressings can be designed by using 
resorbable materials. This line of research has not been sufficiently developed yet, as very few 
biodegradable materials meet all the requirements for wound dressing materials. 
Hence the need for biocompatible materials has instigated research on natural degradable 
polyhydroxyalkanoates (PHAs) as materials for reconstructive surgery, including tissue 
engineering. There is much scientific evidence already reported that PHAs are biocompatible and 
functional polymers [19-22]. Scientific reviews highlight that scaffolds of PHAs facilitate 
proliferation of various cells, including fibroblasts, osteoblasts, chondrocytes, neurons, and stem 
cells [33-41]. Moreover, some data suggest that fibroblasts and keratinocytes grow better on 
scaffolds of PHAs than other materials, including polylactides [42]. Thus, there is a promising 
future for PHAs as materials for constructing tissue-engineered grafts for healing skin wounds. 
Our previous findings have been reported in production of PHA films, membranes, 
microparticles, microgranules, tubes, fibers, etc. and have been successfully used to suture 
musculofascial wounds and perform intestinal anastomosis, as bile duct stents, osteoplastic 
materials, drug delivery systems, etc. [23-32]. In the present investigation, the main focus is to 
construct experimental wound dressings from degradable PHAs intended for skin wound repair 
and evaluate their effectiveness in experiments on laboratory animals. 
2. Materials and Methods 
2.1. Polymer preparation 
Synthesis of polymers was carried out at the Institute of Biophysics SB RAS according to 
the protocol described in the previous report [43]. In the present study, PHA copolymers 
comprising monomers of 3-hydroxybutyric and 4-hydroxybutyric acids [P(3HB/4HB)] were 
used.This is the best PHA for fabricating biomedical products: P(3HB/4HB) has a low degree of 
crystallinity, the highest elasticity, and the fastest rate of biodegradation in vivo. The polymer 
was synthesized in CupriaviduseutrophusB10646 microbial culture (the strain is registered in the 
Russian Collection of Industrial Microorganisms) [44]. Cells were batch-cultured in a 14-L New 
Brunswick Scientific BioFlo 110 fermentor filled with 40 % of its volume with standard mineral 
salts medium: Na2HPO4H2O – 9.1; KH2PO4 – 1.5; MgSO4H2O – 0.2; Fe3C6H5O77H2O – 0.025; 
NH4Cl – 0.5 (g/L); the medium was supplemented with glucose in amounts corresponding to cell 
concentration in the medium. A solution of iron citrate (5 g/L) was used as a source of iron. 
Hoagland’s trace element solution was used with composition 3 ml of standard solution per 1 L 
of the medium. The standard solution contained H3BO3 – 0.288; CoCl26H2O – 0.030; 
CuSO45H2O – 0.08; MnCl24H2O – 0.008; ZnSO47H2O – 0.176; NaMoO42H2O – 0.050; NiCl2 
– 0.008 (g/L). In order to achieve synthesis of P(3HB/4HB) copolymer, the culture medium was 
supplemented with additional carbon substrate (γ-butyrolactone). 
2.2. Analysis of composition and physicochemical properties of P(3HB/4HB) 
Polymer was extracted with chloroform and then precipitated with hexane. The 
composition of PHAs was analyzed with a GC-MS (6890/5975C, Agilent Technologies, U.S.) 
and NMR spectrometry. 1HNMR spectra of copolymer were recorded at room temperature 
inCDCl3 on a BRUKER AVANCE III 600 spectrometer operated at 600.13 MHz. 
Molecular weight and molecular-weight distribution of PHAs were examined using a gel 
permeation chromatograph (Agilent Technologies 1260 Infinity, U.S.) with a refractive index 
detector, using an Agilent PLgel Mixed-C column. Thermal analysis of PHA specimens was 
performed using a DSC-1 differential scanning calorimeter (Mettler Toledo, Switzerland). 
Samples were preheated to 60 °C and cooled to 25 °C. The specimens were heated to 
temperatures from -20°C to 300 °C, at 5 °C×min-1 (measurement precision 1.5 °C). The 
thermograms were analyzed using the STARe v11.0 software. X-Ray structure analysis and 
determination of crystallinity of copolymers were performed employing a D8 ADVANCE X-
Ray powder diffractometer equipped with a VANTEC fast linear detector (Bruker, AXS, 
Germany). Calculations were done by using the Eva program of the diffractometer software. 
 
2.3. Preparation of films and nonwoven membranes 
Thenonwoven membranes made from ultrafine fibers were prepared by electrospinning 
from P(3HB/4HB) solutions using a Nanon 01A automatic set-up (MECC Inc., Japan) according 
to the previously developed technique [45]. A chloroform solution with polymer concentration 
6% was poured into a plastic syringe (13 mm inside diameter). The syringe was fixed 
horizontally in the set-up; the solution feeding rate was 8 ml/h, the applied voltage 25 kV, and 
the working distance 15 cm. Randomly oriented ultrafine fiberswere collected on a flat steel 
plate. Films were prepared by casting a chloroform solution (2 % w/v) on degreased glass and 
subsequent drying at room temperature for 2-3 days in a dust-free box (Labconco, U.S.) [23]. 
 
2.4. Physical and chemical characteristics of nonwoven membranes 
The thickness of films and electrospun nonwoven membranes was measured with a 
LEGIONER EDM-25-0.001 electronic digital micrometer (Legioner, China); accuracy of 
measurement was 1 µm. The microstructures of the surfaces of films and membranes were 
analyzed using scanning electron microscopy (TM 3000, S 5500, Hitachi, Japan). Prior to 
microscopy, the samples were sputter coated with platinum (at 10 mA, for 40 s) with an Emitech 
K575X sputter coater (Quorum Technologies, U.K.). 
The surface properties of the polymer films and membranes were examined using a DSA-
25E drop shape analyzer (Krüss, Germany) and software DSA-4 for Windows. Each drop of 
water and diiodomethane were alternately placed on the sample surface with microsyringes, and 
moments of interaction between each liquid and sample surface were video recorded. The 
contact angles of these liquids were measured by processing the frame of a stabilized drop in a 
semiautomatic mode by the “Circle” method, which is embedded in the software package. The 
results of measurements were used to calculate surface free energy and its dispersive and polar 
components (mN/m) by the Owens, Wendt, Rabel and Kaelble method [46, 47]. A minimum of 
six measurements were taken for each surface; means and standard deviations were calculated. 
The physical/mechanical properties of films and membranes were investigated using an 
Instron 5565 electromechanical tensile testing machine (U.K.). Dumbbell-shaped samples 50 
mm long, 6.1 mm wide, and 30-40 μm thick were prepared for studying physical/mechanical 
properties of the films and 3D constructs. The thickness of films was measured prior to testing, 
using a “LEGIONER EDM-25-0.001” electronic digital micrometer. The samples were 
maintained under normal conditions for at least two weeks to reach equilibrium crystallization. A 
minimum of five samples were tested for each type of films and 3D constructs. Measurements 
were conducted at room temperature; the clamping length of the samples was 30 mm. The speed 
of the crosshead was 3 mm/min at room temperature. Young’s modulus (E, MPa), tensile 
strength (σ, MPa) and elongation at break (ε, %) were automatically calculated by the Instron 
software (Bluehill 2, Elancourt, France). To obtain Young’s modulus, the software calculated the 
slope of each stress-strain curve in its elastic deformation region. The measurement error did not 
exceed 10 %. 
 
2.5. An in vitro study 
2.5.1. In vitro degradation of films and nonwoven membranes 
Biodegradation kinetics of the samples was investigated with in vitro model systems. In 
brief, phosphate buffer solutions with different pH (pH 4.5, 5.9, and 7.0) and human blood 
stabilized with sodium citrate were used. Polymer films and electrospun nonwoven membranes 
with 10 mm-diameter disks were prepared and samples with known physical/mechanical 
properties were weighed and sterilized in a Sterrad NX medical sterilizer (Johnson & Johnson, 
U.S.). Later, under aseptic conditions, the discs were placed into 20-ml dark-glass vials with the 
model medium supplemented with gentamycin (100 g/ml). The samples were maintained at 37 
°C for 100 days, with the medium replaced with a fresh one every week. The biodegradation of 
the films and membranes was evaluated by measuring the mass of the samples. Every 25 days, 
the samples (three of each type) were removed from the model environments, washed with 
distilled water, brought to a constant weight, and weighed on an analytical balance of the first 
grade of accuracy and any changes in mass (X) were determined using the formula: 
Y1 - Y2 
Х [%] = ___________100, 
 
2.5.2. Isolation of MSCs from adipose tissue 
MSC s were derived from the adipose tissue of Wistar rats which were euthanized by 
using an overdose of an anesthetic ether. The adipose tissue was isolated under aseptic 
conditions from the rats’abdominal and femoral regions; later it was excised into small pieces to 
prepare a homogeneous mass and rinsed thrice with physiological saline buffered with 
phosphates containing antibiotics (100 units/ml of penicillin, 100 µg/ml of streptomycin). The 
suspension was supplemented with type 1 collagenase solution and incubated for 60 min in a 
CO2 incubator at 37 °C, with shaking every 15 min. The adipose tissue was thoroughly mixed to 
prepare a homogeneous suspension, and the cells were precipitated by centrifugation for 10 min 
at 1500 g. The supernatant was removed and the sediment was resuspended in a complete 
DMEM medium. The cell suspension was transferred into 90-mm-diameter Petri dishes and 
placed into CO2 incubator for 24 h. After 24 h, the medium was replaced by a fresh solution and 
unattached cells were removed. MSC differentiation into fibroblasts was induced by using the 
DMEM medium with 10 % fetal bovine serum and a solution of antibiotics (100 units/ml of 
penicillin and 100 µg/ml of streptomycin). In DMEM medium, adipose tissue cells showed 
fibroblast-like morphology. After 3-4 passages, the cells were removed from Petri dishes with a 
trypsin solution and seeded onto sterile PHA membranes at a concentration of 105 cells per 
scaffold. Gene expression of collagen type I (Col-1) was determined by real time RT-PCR, to 
confirm the fibroblast phenotype of the cells and their viability. Fibroblast marker gene 
expression was determined by cell lysis and isolation of mRNA, using an RNA-Extran reagent 
kit (Sintol, Russia). The encoding DNA was obtained by reverse transcription reaction, using the 
reverse transcriptase MMLV (Sintol, Russia). RT-PC-reaction was performed using specific 
primers, with a Real-time CFX96 Touch amplifier (Bio-Rad LABORATORIES Inc., U.S.) 
according to the manufacturer’s guidelines. During the reactionprocess, β-actin was used as a 
housekeeping gene. The relative level of expression of the marker genes was determined by the 
relative threshold cycle method (2–ΔΔCt). 
 
2.5.3. Seeding MSCs onto scaffolds 
Polymer films and electrospun nonwoven membranes with 10 mm-diameter disks were 
placed into 24-well culture plates (TPP Techno Plastic Products AG, Switzerland) and sterilized 
in a Sterrad NX medical sterilizer (Johnson & Johnson, U.S.).Scaffolds were seeded with cells at 
a concentration of 105 for 7 days. Cells were cultured on the DMEM medium with 10 % fetal 
bovine serum and a solution of antibiotics (Sigma-Aldrich reagents) in the 5 % CO2 atmosphere 
at 37 °C, with the medium replaced by a fresh one every three days. 
Cell viability was evaluated using MTT assay. A 5 % MTT solution (50 µl) and a 
complete nutrient medium (950 µl) were added to each well of the culture plate. After 3.5 h 
cultivation, the medium and the MTT solution were replaced by DMSO to dissolve MTT-
formazan crystals. After 30 min, the supernatant was transferred to the 96-well plate, and optical 
density of the samples was measured at a wavelength of 540 nm, using a Bio-Rad 680 microplate 
reader (Bio-Rad LABORATORIES Inc, U.S.). The number of viable cells was determined from 
the calibrated graph. 
Cell cytoplasm and nuclear DNA molecules were stained with phalloidin conjugated with 
fluorescein (FITC) and DAPI respectively (Sigma–Aldrich, U.S.), to observe cell morphology 
and to count the cells attached to scaffolds.The scaffolds with cells were fixed in a 3.7 % 
formaldehyde solution for 60 min and then rinsed in phosphate buffered saline to remove the 
fixative. Later the scaffolds with attached cells were incubated in a Triton X-100 solution (0.1 
%) (GERBU Biotechnik GmbH, Germany) for 5 min followed by a 1 % bovine serum albumin 
solution (Ampresco, U.S.) for 30 min at room temperature. Cell cytoplasm was stained with a 
FITC solution (a 1/100 dilution) for 60 min at room temperature; nuclei were contrasted with 
DAPI (a 300 nM solution, for 5 min). The cells were examined using a Leica fluorescence 
microscope (Leica Microsystems). 
2.6. An in vivo study 
The efficacy of nonwoven polymer membranes prepared by electro-spinning from 
P(3HB/4HB) copolymers was studied on model skin defects induced in Wistar rats. Experiments 
were conducted in accordance with the Animal Welfare Act and the Guidelines for Ethical 
Treatment of Animals. 
2.6.1. Surgical protocol 
The rats were given an in halation anesthetic and a 2×2-cm section in the inters capular 
region of each rat was shaved and then excised (both epidermis and dermis, to its full thickness) 
under aseptic conditions and average wound area of 4.0-4.5 cm2 was selected. The experiment 
was conducted with three sets of animals: two treatment groups, one with the grafts of nonwoven 
membranes and second with membranes carrying epidermal cells derived from adipose tissue. 
The third group served as control whose wound was covered with sterile gauze. The dressings 
were fixed with 4 sutures and covered with sterile gauze. The state of the animals (motion 
activity, feeding behavior) was assessed daily throughout the experiment. The wounds were 
photographed and the area of the wound and the rate of healing were determined in order to 
monitor wound healing. 
2.6.2. Histologic examination 
For histologic examination, skin samples were excised after the animals were euthanized, 
at Days 3, 7, and 14 of the experiment. The specimens were fixed in 10 % neutral formalin and 
conventional histological techniques were used. During investigation, evaluation of the 
inflammatory reaction and acanthosis (an indicator of increased proliferation of basal and 
spinous cells), counting of horn cysts (a marker of the lagging cell differentiation in the 
epidermis under the conditions of accelerated regeneration), quantification of sebaceous glands 
and hair follicles (a source of undifferentiated epithelial cells that can be involved in regeneration 
of the epidermis in the case of vast shallow wounds) were carried out. 
2.6.3.Analysis of expression of regenerative factors using real-time PCR (RT-PCR) 
To get an insight into the mechanism of the wound healing process, gene expression 
studies were carried out to detect the factors that characterized the degree of inflammatory 
process, vascularization, and formation of the new connective tissue at the defect site. Real-time 
RT-PCR was performed in the region of quantification of gene expression for factors of rat 
angiogenesis (VEGF), inflammation (TNF-a), collagen type I (Col-1) (an indicator of connective 
tissue formation), keratin 10 (K10), and keratin 14 (K14) (indicators of the formation of the 
spinous and granulosa layers of the epidermis during regeneration) to determine the 
quantification level of  transcription of genes responsible for inflammation, vascularization, and 
connective tissue formation. Total RNA was isolated from the granulation tissue of the treatment 
and control groups by extraction with a guanidinium thiocyanate-phenol-chloroform mixture 
from the RNA-Extran reagent kit. Later, from RNA template by using reverse transcriptase, 
cDNA  was synthesized with several types of oligonucleotide primers: with a mixture of random 
primers – hexa primers – and oligo-dT primer, following the procedure recommended by the 
manufacturer (Sintol, Russia). Negative controls of reverse transcription reaction were prepared 
for all samples to confirm the absence of DNA contamination in the initial RNA. Real-time 
PCR-amplification for quantification of cDNA fragments of rat VEGF, rat TNF-a, rat Col-1, rat 
K10, and rat K14 were performed by using a CFX-96 thermocycler, according to the 
manufacturer’s protocol, using the color channel of HEX. 
2.7. Statistics 
Statistical analysis of the results was performed by conventional methods using the 
standard software package of Microsoft Excel. Arithmetic means and standard deviations were 
found. The statistical significance of results was determined using Student’s test (significance 
level: P ≤ 0.05). Statistical analysis of surface properties of the samples was performed by using 
embedded methods of the DSA-4 software. 
 
3. Results 
3.1. Characterization of cell scaffolds based on P(3HB/4HB) 
The characterization of cell scaffolds results showed the presence of 3HB and 4HB 
monomer units, 90/10 mol. %, which was confirmed with 1H NMR spectrum of P(3HB/4HB) 
(Fig. 1). P(3HB/4HB) displayed the following: degree of crystallinity (Cx) 50 %, average 
molecular weight (Mw) 473 kDa, polydispersity (Ð) 3.26, melting point (Tmelt) 154 °C and 
thermal decomposition temperature T(degr) 286 °C. 
Similarly, morphological characteristics were studied with SEM analysis which revealed 
the micrograms with different surface morphology of wound dressings prepared by different 
techniques. The solution cast P(3HB/4HB) films with a 9:1 ratio had round pores up to 2 µm in 
diameter (Fig. 2). The nonwoven membranes composed of randomly oriented ultrafine fibers 
showed distinct fibers with an average diameter of 1.7 µm and the distance between them was 
found to be 1.3 – 1.67 µm. The comparative study of the surface properties and 
physical/mechanical properties of the wound dressings are given in Table 1.  It was also found 
that the films and nonwoven membranes had similar water contact angles at around 75.7-76.9 ° 
with different diiodomethane contact angles at 55.1 and 43.5 °. Interestingly, when their surface 
properties were compared it was observed that they differed in their physical/mechanical 
characteristics. The elongation measurement at broken end indicated the elasticity of products 
with order of magnitude higher in membranes than in films, displaying  higher parameters of 
mechanical strength including Young’s modulus and tensile strength. The water vapor 
permeability of films and membranes P(3HB/4HB) was determined, and this parameter was 
higher by a factor of more than 20 in the electrospun membranes than in the solution cast films. 
3.2. An in vitro study 
An in vitro analysis was carried out by measuring the mass of the films and membranes at 
pH 5.9. (Figure 3), which showed no change in their mass nor tensile strength throughout the 
observation period of 100 days. Similar results were also obtained at pH values (4.5 and 7.0). 
The obtained result indicated that polymer samples prepared from P(3HB/4HB) were not 
degraded in the phosphate buffer solutions at different pH used in the experiment. The 
hydrophobic films and membranes maintained in the phosphate buffer solution for 24 h did not 
show any swelling which was confirmed by measuring  their mass. In order to confirm further, a 
chromatographic analysis of the medium was carried, which showed the absence of 3HB and 
4HB monomers. Thus, the stability of the product was proved and there was no sign of 
hydrolysis. However, samples incubated in the biological medium (stabilized blood) were 
degraded by enzymes (Fig. 3). The mass reduction was first detected after 25 days of incubation 
and during 100 days of incubation, the mass reduction of the nonwoven membranes reached up 
to 34 %, while the mass of the films was decreased by 25 %. The physical/mechanical 
parameters of the films and membranes measured after incubation in the phosphate buffer 
solution for 100 days is described in Table 1. The mechanical strength of the films and 
membranes incubated in blood showed a gradual decrease from Day 50, as the samples were 
degraded. After 100 days of incubation, all parameters decreased by 26-32 % of their initial 
values (Table 1). 
The prepared films and membranes were seeded with cells isolated from the rat adipose 
tissue. Adipose tissue cells growing on the polystyrene of the culture plates were used as the 
control. The process of growth was measured with MTT assay (Fig. 4 a) which showed that  at 
Day 7 after seeding, the number of viable cells on the nonwoven membranes was 2.4 × 105 
cells/cm2, which was 25 and 30 % higher than the number of cells on polymer films and control 
(polystyrene), respectively. In the DMEM medium, adipose tissue cells acquired the fibroblast 
phenotype and synthesized Col-1, which was confirmed by expression studies using  real-time 
RT-PCR in the region of the quantitative evaluation of gene expression to the factors of Col-1 
(Fig. 4 b). The DNA copy number was also higher on the nonwoven membranes. The results of 
quantification of Col-1 by real-time PCR were confirmed by immunocytochemical staining as 
shown in figure 5 indicating the immunocytochemical staining with Col-1 antibodies at Day 14 
of adipose tissue cell culture. Interestingly, cells growing on films and nonwoven PHA 
membranes showed higher rate of collagen synthesis than in the cells growing in the DMEM 
medium on polystyrene (control). 
Thus, as the cells showed better proliferative and synthetic activities on nonwoven 
membranes than on the smooth films, the nonwoven membranes were chosen for constructing 
hybrid tissue-engineered grafts carrying fibroblast cells. The electrospun membranes (scaffolds) 
used for constructing grafts were composed of randomly oriented ultrafine fibers and during the 
electrospinning the fibers were collected on a flat plate. 
3.3. An in vivo study 
Throughout the postoperative observation period, all animals were healthy and active 
with normal eating behavior and moved on their own. After the treatment group animals 
awakened from anesthesia, they did not show any signs of pain. Complete blood counts showed 
the following: until Day 4, the leukograms of all animals had demonstrated slight lymphopenia, 
an increase in band neutrophils to 4% and there was an increase in segmented neutrophils up to 
1.2%. The day after the defect was created, counts of erythrocytes and hemoglobin decreased 
and the animals developed leukocytosis. The counts of erythrocytes and hemoglobin had 
returned to their initial levels by Day 3 in the treatment groups and by Day 7 in the control. Thus, 
insignificant changes in some of the parameters of peripheral blood (elevated ESR and moderate 
leukocytosis) in the first week post surgery were part of the natural response of the body to 
surgical intervention. 
Measurements of the wound area suggested that in the treatment groups, the defects 
repaired faster (Fig. 6). Photographs of the wounds taken during the experiment are shown in 
Figure 7. Histology of the skin samples excised at the wound regions showed usual tissue 
response to surgical intervention, characteristic of the healing process including phases of post-
traumatic inflammation, connective tissue formation, cicatrix formation and restructuring along 
with wound epithelialization. Inflammation was observed in the wound region in all animals but 
the hyperemia of the dermis vessels and cell infiltration of the dermis were pronounced to 
different extents depending on the group. In the control group, large amounts of seropurulent 
exudate containing leukocytes were localized under the surface necrotic masses. In the group 
with nonwoven P(3HB/4HB) membranes seeded with epidermal cells, hyperemia of the vessels 
was less pronounced and there was no purulent exudate. That was a usual post-traumatic tissue 
response with moderate aseptic inflammation, which subsided rather quickly and was followed 
by tissue formation processes. 
Measurements of the wound surface area showed significant changes in the group with 
membranes seeded with epidermal cells. During the initial days, the wound decrease rate was the 
highest: 0.4-0.65 cm2/d; at Day 3 the wound area was 3.6 cm2 (81 % of the initial wound area). 
Later at Day 5, the wound area constituted 62.7 % of its initial area, similarly at Day 7 the wound 
area was found to be 57 % and at Day 14 it was 9 %. The group consisting of PHA membranes 
showed lower healing rate of 0.3-0.4 cm2/d. At Day 3, the wound areadecreased by 9 % (91 % of 
the initial area) and at Day 7, the wound area constituted 78 % of the initial area and at Day 14 it 
was found to be 9.1 %. This result was comparable with the results obtained from the group with 
membranes carrying cells. In the control group, during the first 24 h post-surgery, the healing 
rate was 0.16-0.23 cm2/d. 
In the group with nonwoven membranes without cells, the average healing rate was 
lower: 0.45 cm2/d. At Day 5, the area of the wound decreased to 62.7 % in comparison with the 
initial wound area and at Day 7 it decreased to 57 % and at Day 14 it was found to be 9.1 %. In 
the control group, the wound healing rate was lower in comparison with the treatment groups 
which showed 0.16-0.23 cm2/d and the area of the wound decreased by 4 % by Day 5. At Day 7, 
a decrease in the wound area reached 23 % and at Day 14 it was found to decrease by 30 % of 
the initial wound area. 
In order to elucidate the mechanism of the wound healing process, a study was carried out 
to determine the factors that characterized the degree of inflammatory process, vascularization, 
and formation of the new connective tissue at the defect site. Real-time RT-PCR was performed 
in the region of quantification of gene expression to the factors of rat angiogenesis (VEGF), 
inflammation (TNF-a), collagen type I (Col-1) (an indicator of connective tissue formation), 
keratin 10 (K10) and keratin 14 (K14) (indicators of the formation of the spinous and granulosa 
layers of the epidermis during regeneration). Total RNA content was isolated from the 
granulation tissue of the treatment and control groups. The extraction of RNA was carried out 
using guanidinium thiocyanate-phenol-chloroform mixture from the RNA-Extran reagent kit. 
Later, from the RNA template, using reverse transcriptase, cDNA was synthesized using several 
types of oligonucleotide primers which included a mixture of random primers –hexa primers – 
and oligo-dT primer according to the protocol described by the manufacturer (Sintol, Russia). 
Negative controls of reverse transcription reaction were prepared for all samples to confirm the 
absence of DNA contamination in the initial RNA. Real-time PCR-amplification for 
quantification of cDNA fragments of rat VEGF, rat TNF-a, rat Col-1, rat K10 and rat K14 were 
performed by using a CFX-96 thermocycler, according to the manufacturer’s protocol using the 
color channel of HEX. 
During the first 24 h, all animals developed edemas, which were more pronounced in the 
control group. The histology of the new tissue collected from the defect site at Day 3 showed that 
in the control group, there was formation of connective tissue with very few collagen fibers and 
blood vessels. Vascularization was more pronounced under the experimental wound dressings, 
which was confirmed by the PCR of VEGF gene expression as an indicator of blood vessel 
formation (Fig. 8 a). 
The wounds covered with the polymer membrane dressings of P(3HB/4HB) displayed the 
density of newly formed collagen fibers which was higher than the control. Further, at Day 7 the 
total cell counts in the dermis under the wound surface were slightly lower in the treated groups 
which were studied under the microscope. It was also observed that there was a clear shift 
towards fibroblast cells, suggesting faster reduction in the inflammatory process, which had 
developed at the defect site. The faster inflammation reduction in the treatment groups was 
confirmed in the PCR-based tests of TNF-α gene expression (inflammation factor) (Fig. 8 b). 
The results of planimetric measurements (Fig. 6) and analysis of histological sections (Fig. 9 a), 
which suggested faster regeneration of the defects in the treatment groups, were confirmed by 
counting hair follicles, sebaceous glands, and horn cysts, as objective indicators of wound 
healing (Table 2). 
Regeneration started earlier in the treatment groups, in which hair follicles and sebaceous 
glands were detected at Day 7, whereas only horn cysts, a marker of the lagging cell 
differentiation in the epidermis was detected in the control group. 
The results of PCR-based assays of gene expression of collagen type I (Col-1) (an 
indicator of connective tissue formation), keratin 10 (K10) and keratin 14 (K14) (indicators of 
the formation of the spinous and granulosa layers of the epidermis during regeneration) showed 
that new tissues developed were considerably better and wound healing rate was faster in the 
treated groups under experimental polymer membranes. The numbers of Col-1, K10, and K14 
cDNA copies were higher than those in the control by factors of 4.0-5.0, 3.5-4.0 and 4.0–4.5, 
respectively (Fig. 9 b). 
Counts of hair follicles, sebaceous glands, and horn cysts as objective indicators of 
wound healing process are listed in Table 2. Sebaceous glands and hair follicles are sources of 
undifferentiated epithelial cells (structurally the same as basal cells), which take part in skin 
regeneration. 
 
4. Discussion 
Reconstructive medicine needs novel materials for effective regeneration of skin injured 
due to burns, traumas, and surgical interventions. Skin replacements in the form of films have 
been increasingly used recently. These are fabricated from various natural and synthetic 
materials: collagen, polyvinylchloride, polyethylene, polypropylene, polyethylene terephthalate, 
poly-epsilon-caprolactone, etc. Skin grafts made of resorbable polymers such as polyvinyl 
alcohol (PVA), poly(lactide-co-glycolide) (PLGA) blended with chitosan and collagen, 
polycaprolactone (PCL), gelatin, and glucosamine glycans were tested as skin wound dressings 
in experiments on laboratory animals [1-3, 48-51]. Many of the films are sufficiently strong and 
supple; they are convenient to use. However, these wound dressings do not have sufficient vapor 
permeability. Hydrophilic polyurethane films hold much promise; the best known representatives 
of these films are Op-Site and Tegaderm. These wound dressings are convenient to use, elastic, 
and transparent; they adhere well to the wound surface. Fixomull Stretch is a highly adhesive, 
water and vapor permeable wound dressing consisting of a white nonwoven polyester substrate 
coated with a skin-friendly polyacrylate adhesive. At the same time, vapor permeability of the 
majority of such dressings is too low. Omiderm, which is made of elastic hydrophilic 
polyurethane, has much better vapor permeability and, which is very important, can be used in 
combination with antibacterial drugs. A special group of wound dressings used in management 
of burn injuries comprises non-adhesive dressings. Non-adhesive wound dressings Adaptic 
(Johnson & Johnson) and Damo (Damor America Inc.) are impregnated with non-smearing 
ointments, emulsions or creams. Skintact (Robinson) is a wound dressing that shows low 
adherence and high absorptive ability. 
Wound dressings are used in the treatment of various wounds, but traditional bandages 
are growing out of use. Scientific achievements enabled creation of modern wound dressings, 
which have different properties depending on the phase of wound healing in which they are used. 
Resorbable wound dressings meet all biomedical requirements and can be useful in both early 
and late phases of wound healing. Prolonged-action formulations are usually based on high-
molecular-weight polymer materials which are degraded in the body without releasing toxic 
substances. Designing resorbable polymer wound dressings with different biodegradation rates is 
one of the important objectives of biomedical research. There is great activity in searching for 
new functional materials and scaffolds. 
The present study is an investigation of experimental wound dressings prepared from the 
P(3HB/4HB) copolymer — the most promising representative of PHAs for biomedical 
applications — which has a low degree of crystallinity, the highest elasticity, and the fastest rate 
of biodegradation in vivo [32, 45]. It is not by chance that the first medical products for which 
Tepha (U.S.) obtained permission from FDA for clinical use were fabricated from PHAs 
composed of 4-hydroxybutyrate monomers. 
The first stage of the present study deals with degradability of casting films and 
nonwoven membranes composed of randomly oriented ultrafine fibers of P(3HB/4HB) in vitro, 
in the phosphate buffer solution and in stabilized blood. In contrast to polylactide/glycolide 
nonwoven membranes, which were degraded in Ringer’s solution at different rates, depending on 
the component ratio [52]. In the present study, P(3HB/4HB) films and membranes were only 
degraded in the biological medium (blood), with just inconsiderable strength losses (between 26 
and 32 % of the initial values), but were stable in the phosphate buffer solution. These results 
were consistent with the data obtained in our previous studies reporting monofilament fibers of 
P(3HB) and P(3HB/3HV) [53]. 
Therefore, in the present study, both smooth films and nonwoven membranes of 
P(3HB/4HB) were used as scaffolds for culturing adipose tissue MSCs. The characterization 
studies using electron microscopy and staining of cells with fluorescent dyes and MTT assay 
confirmed the elasticity of nonwoven membranes containing ultrafine fibers which were 
produced by electrospinning and also had more functional cell scaffolds. The study also 
confirmed more effective MSC differentiation into fibroblasts which was supported with gene 
expression studies of collagen type I (Col-1) using real time RT-PCR techniques. The cells 
cultivated on P(3HB/4HB) membranes synthesized 20 % more extracellular matrix proteins, 
such as collagen type 1, than cells on films. These results are consistent with the data reported in 
previous studies, which showed that nonwoven electrospun membranes had interconnected 
porous structure and a high surface area to volume ratio and acted as better scaffolds for 
fibroblast, keratinocyte and epithelial cell cultures than films [17, 54-56]. According to the study 
conducted by Blackwood et al. [52], the nonwoven membranes of polylactide/glicolide 
effectively facilitated the growth of human keratinocytes, fibroblasts and endothelial cells in 
mono- and bi-culture enabling collagen production on scaffolds of PLGA with the component 
ratios of 75:25 and 85:15. Similarly, Sharma et al. [14] reported successful construction of grafts 
for skin regeneration consisting of two-layer nonwoven membranes with a donor’s skin flap as 
interlayer. These results were in accordance with the present investigation of the in vitro study 
using P(3HB/4HB) films and nonwoven membranes in the MSC culture. In the present study, the 
use of nonwoven electrospun membranes to construct biotechnological wound dressings (grafts) 
was evaluated on experimental laboratory animals. 
The scientific studies reveal less reports available on PHA polymers as material for 
constructing wound dressings. In recent years, much more attention has been focused on grafts of 
polylactides and polylactide/glycolide copolymers [1-3, 14]. Studies also highlight that 
membranes of 3-hydroxybutyrate-co-3-hydroxyhexanoate [P(3HB/3HHx)] were investigated as 
scaffolds for tarsal repair in eyelid reconstruction in rats; the results were compared with 
implantation of commercial dermal matrices (ADM) purchased from ReDerm (Jieya Company, 
China), and the authors reported that the P(3HB/3HHx) implants repaired the defect, causing a 
less pronounced tissue response than the commercial matrices. They concluded that the 
P(3HB/3HHx) membrane was proven to be a suitable candidate for tarsal repair [57]. In a study 
conducted by Murueva et al. [58] it was reported that P(3HB) microparticles loaded with 
nonsteroidal anti-inflammatory drugs (diclofenac and dexamethasone) were used in experiments 
on laboratory mice with experimental skin wounds caused by chemical burns. Treatment with 
anti-inflammatory drugs encapsulated in polymeric microparticles made of degradable polymer 
accelerated wound healing compared with routine therapy (estimated by the area of burn wound, 
wound healing activity, the number of acanthotic cells, and the number of hair follicles and 
sebaceous glands). The results showed that drug-loaded degradable polymeric microparticles 
could be promising candidates for treatment of skin defects. 
In the present study, the efficacy of using nonwoven membranes of P(3HB/4HB) was 
studied on model skin defects in Wistar rats. The results displayed insignificant changes in the 
parameters of peripheral blood in the initial days. The post-surgery effects were part of the 
natural response of the body to surgical intervention. Histologic examination and measurements 
of the wound surface area showed that both cell-free and cell-seeded membranes facilitated 
wound healing. Histology of the skin samples excised at the wound regions showed usual tissue 
response to surgical intervention characteristic of the healing process. The nonspecific 
inflammation observed in all groups of animals was a typical posttraumatic tissue response and 
part of the natural healing process. In the group with nonwoven P(3HB/4HB) membranes seeded 
with epidermal cells, hyperemia of the vessels was less pronounced and there was no purulent 
exudate. The wounds under the P(3HB/4HB) membrane carrying cells healed 1.4 times faster 
than the wounds under the cell-free membrane and 3.5 times faster than the wounds healing 
under the eschar (control). In the “membrane+cells” group, complete healing was achieved at 
Day 14. A similar study was carried out with films of 3-hydroxybutyrate-co-3-hydroxyvalerate 
[P(3HB/3HV)] at the V.I. Shumakov Federal Research Center for Transplantology and Artificial 
Organs of Rosmedtekhnologii. The films were found to be suitable scaffolds for culturing MSCs 
and epidermal cells for various applications, including skin wound repair [59]. Similarly, 
polymer films of P(3HB/3HV) blended with polyethylene glycol (ElastoPOB) carrying bone 
marrow mesenchymal stem cells were studied. Experiments on laboratory animals with model 
defects of the skeletal muscle and burn wounds showed that the polymer material effectively 
immobilized the cells and delivered them to the defect site for therapy [60]. Overall, the study 
reported that nonwoven polymer membranes P(3HB/4HB) and membranes carrying epidermal 
cells (grafts) on laboratory animals showed that they conformed to the wound surface in all 
areas, protected the wound, and facilitated reparative processes, enabling the wounds to heal 
faster than the wounds covered with the gauze dressing. The polymer membranes prepared and 
tested in this study can be used to reduce inflammation, enhance angiogenic properties, and 
facilitate skin regeneration. 
During histologic examination of tissue sections, we counted hair follicles, sebaceous 
glands, and horn cysts at the defect site as objective indicators of the healing process. The 
number of hair follicles and sebaceous glands, which are sources of undifferentiated epithelial 
cells taking part in skin regeneration, was greater in the group with nonwoven polymer 
membranes than in the control group even at Day 7 post surgery, and at Day 14 it was 3-5 times 
as large. The number of horn cysts, which indicate lagging differentiation of dermal cells, 
reached 7 in the control group at the end of the experiment, while in the groups with 
experimental membranes, no horn cysts were observed not only at Day 14 but also at Day 7. 
By using molecular methods, we managed to characterize the wound healing process and 
mechanism. The faster inflammation reduction in the treatment groups, with experimental wound 
dressings, was confirmed in the PCR-based tests of TNF-α gene expression (inflammation 
factor). The results of PCR-based test of gene expression of collagen type I (Col-1) (an indicator 
of connective tissue formation), keratin 10 (K10) and keratin 14 (K14) (indicators of the 
formation of the spinous and granulosa layers of the epidermis during regeneration) also showed 
that new tissues developed considerably better and wound healing rate was faster under 
experimental polymer membranes. The numbers of Col-1, K10, and K14 cDNA copies were 
higher than those in the control by factors of 4.0-5.0, 3.5-4.0, and 4.0–4.5, respectively. 
Thus, using morphological, histological, and molecular methods, we showed that 
nonwoven electrospun membranes of P(3HB/4HB), especially when combined with fibroblasts, 
facilitated wound healing. 
 
Conclusion 
Solution-cast films and nonwoven electrospun membranes composed of ultrafine fibers 
were prepared from P(3HB/4HB) solutions and tested as experimental wound dressings. The 
films and membranes did not swell in the phosphate buffer solution and were not hydrolyzed in 
it, but they were slowly biodegraded, without dramatically losing their mechanical strength, in 
stabilized blood. Nonwoven membranes were more effective than smooth films as scaffolds for 
MSC culture and MSC differentiation into fibroblasts. The nonwoven polymer membranes and 
grafts based on them were investigated in experiments on laboratory animals with model skin 
defects. The experimental membranes fitted the wound shape, protected the wound from external 
influences, and facilitated wound healing, promoting fast wound repair. Employing 
morphological, histological and molecular methods, we showed that nonwoven membranes 
combined with cells synthesizing growth factors facilitated wound healing, neovascularization 
and regeneration and enabled complete wound healing by Day 14 post surgery. The use of 
nonwoven membranes of degradable P(3HB/4HB) as atraumatic wound dressings can reduce the 
inflammation, enhance the angiogenic properties of the skin, and facilitate its healing. 
 
Acknowledgements 
The study was supported by the State budget allocated to the fundamental research at the 
Russian Academy of Sciences (project No 01201351505). 
 
References 
1.        MacNeil S. Progress and opportunities for tissue-engineered skin. Nature 2007;445:874-80. 
2. MacNeil S. Biomaterials for tissue engineering of skin. Materials Today 2008;11:26-35. 
3. Canto`n I, Cole DM, Kemp EH, Watson PF, Chunthapong J, Ryan AJ, MacNeil S, Haycock 
JW. Development of a 3D Human In Vitro Skin Co-Culture Model for Detecting Irritants in 
Real-Time. BiotechnolBioeng. 2010;106:794–803. 
4.         Deshpande P, Ramachandran C, Sangwan VS, MacNeil S. Cultivation of Limbal Epithelial 
Cells on Electrospun Poly(lactide-co-glycolide) Scaffolds for Delivery to the Cornea. In: Wright 
B, ConnonCJ, editors. Corneal Regenerative Medicine, Methods and Protocols. New York: 
Humana Press; 2013; 179-185. 
5. Seland H, Gusafson C-J, Johnson H, Junker JPE, Kratz G. Transplantation of acellular 
dermis and keratinocytes cultured on porous biodegradable microcarriers into full-thickness skin 
injuries on athymic rats. Burns 2011;37:99-108. 
6. Metcalfe AD and Ferguson MWJ. Tissue engineering of replacement skin: the crossroads 
of biomaterials, wound healing, embryonic development, stem cells and regeneration. JR Soc 
Interface 2007;4:413–437. 
7.             Walker MNM, Wright KT, Fuller HR, MacNeil S, Johnson WEB. Mesenchymal stem 
cell-conditioned medium accelerates skin wound healing: An in vitro study of fibroblast and 
keratinocyte scratch assays. Exp cell res. 2010;316:1271 – 1281. 
8. Walker NG, Mistry AR, Smith LE, Eves PC, Tsaknakis G, Forster S, Watt SM, MacNeil 
S. A Chemically Defined Carrier for the Delivery of Human Mesenchymal Stem/Stromal Cells 
to Skin Wounds. Tissue eng. Part C 2012;18:143-155. 
9. Blais M, Parenteau-Bareil R, Cadau S, Berthod F. Concise review: tissue-engineered skin 
and nerve regeneration in burn treatment. Stem Cells Transl Med. 2013;2:545-51. 
10. Kim SS, Gwak SJ, Choi CY, Kim BS. Skin regeneration using keratinocytes and dermal 
fibroblasts cultured on biodegradable microspherical polymer scaffolds. J Biomed Mater Res B 
ApplBiomater. 2005;75:369-77. 
11. Liu P, Deng Z, Han S, Liu T, Wen N, Lu W, Geng X, Huang S, Jin Y. Tissue-Engineered 
Skin Containing Mesenchymal Stem Cells Improves Burn Wounds. Artif Organs 2008;32:925–
931. 
12. Yang EK, Seo YK, Youn HH, Lee DH, Park SN, Park JK. Tissue Engineered Artificial Skin 
Composed of Dermis and Epidermis. Artif Organs 2000;24:7-17. 
13.        MacNeil S, Shepherd J, Smith L. Production of Tissue-Engineered Skin and Oral Mucosa 
for Clinical and Experimental Use. In: Haycock JW, editor. 3D Cell Culture, Methods and 
Protocols. New York: Humana Press; 2011. pp. 129-153. 
14.        Sharma K, Bullock A, Ralston D, MacNeil S. Development of a one-step approach for the 
reconstruction of full thickness skin defects using minced split thickness skin grafts and 
biodegradable synthetic scaffolds as a dermal substitute. Burns 2014;40:957–965. 
15. Sill TJ, von Recum HA. Electrospinning: Applications in drug delivery and tissue 
engineering. Biomaterials 2008;29:1989-2006. 
16. Rošic R, Kocbek P, Pelipenko J, Kristl J, Baumgartner S. Nanofibers and their biomedical 
use. Acta Pharm. 2013;63:295–304. 
17.        Despande F, Ramachandran C, Sangwan VS. Cultivation of limbalepithelian cells on 
electrospun poly(lactide-co-glicolide) scaffolds for delivery to the cornea. Method Mol Biol. 
2013;1014:179-185. 
18.        Ramalingman M, Seeram R. Nano-featured scaffolds for tissue engineering: a review of 
spinning methodologies. Tissue Eng. 2006;12:437-4470. 
19.        Williams SF, Martin DP. Applications of PHAs in Medicine and Pharmacy. Steinbüchel A., 
editor. Series of Biopolymers in 10 vol. VCY Verlag GmbH: Willey 2002;4:91–121. 
20. Chen G-Q http://www.sciencedirect.com/science/article/pii/S0142961205003510 - 
cor1mailto:chengq@mail.tsinghua.edu.cn and Wu Q. The application of polyhydroxyalkanoates 
as tissue engineering materials. Biomaterials 2005;26:6565–6578. 
21. Hazer B and Steinbüchel A. Increased diversification of polyhydroxyalkanoates by 
modification reactions for industrial and medical applications. ApplMicrobiolBiotechnol. 
2007;74:1–12. 
22. Martin DP, Badhwar A, Shah DV, Rizk S, Eldridge SN, Gagne DH, Ganatra A, Darois RE, 
Williams SF, Tai H-C, Scott JR. Characterization of poly-4-hydroxybutyrate mesh for hernia 
repair applications. J surg res. 2013;184:766-73. 
23. Shishatskaya EI, Volova TG. A comparative investigation of biodegradable 
polyhydroxyalkanoate films as matrices for in vitro cell cultures. J Mater Sci-Mater M. 
2004;15:915-923. 
24. Volova TG and Shishatskaya EI. Results of biomedical studies of PHAs produced in 
Institute of Biophysics SB RAS and Siberian Federal University. Chapter № 21 in the book 
«Polyhydroxyalkanoates (PHA): Biosynthesis, Industrial Production and Applications in 
Medicine». Nova Scienses Publ. Inc. NY. USA; 2014. pp. 273-330. 
25.          Shishatskaya EI, Volova TG, Efremov SN, Puzyr AP, Mogilnaya OA. Tissue response to 
the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci-Mater М. 
2004;15:719-728. 
26. Shishatskaya EI, Chlusov IA, Volova TG. A hybrid PHA-hydroxyapatite composite for 
biomedical application: production and investigation. J BiomaterSciPolym Ed. 2006;17:481-498. 
27. Shishatskaya EI, Voinova ON, Goreva AV, Mogilnaya OA, Volova TG. Biocompatability 
of polyhydroxybutyrate Microspheres: in vitro and in vivo evaluation. Journal of Siberian 
Federal University. Biology 2008;1:66-77. 
28. Shishatskaya EI, Kamendov IV, Starosvetsky SI, Vinnik YS, Markelova NM, Shageev AA, 
Khorzhevsky VA, Peryanova OV, Shumiliva AA. An in vivo study of osteoplastic properties of 
resorbable poly-3-hydroxybutyrate in models of segmental osteotomy and chronic osteomyelitis. 
Artif Cells Nanomed Biotechnol. 2014;42:344-355. 
29. Volova TG, Shishatskaya EI, Sinskey AJ. Degradable Polymers: Production, Properties and 
Applications. USA: Nova Science Pub., Inc. NY; 2013. 
30.        Goreva AV, Shishatskaya EI, Kuzmina AM, Volova TG, Sinskey AJ. Microparticles 
prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic 
drug. J Mat Sci-Mater M. 2013;24:1905-1915. 
31.         Eke G, Kuzmina AM, Goreva AV, Shishatskaya EI, Hasirci N, Hasirci V. In vitro and 
Transdermal Penetration of PHBV Micro/Nanoparticles. J Mater Sci-Mater M. 2014;25:1471-
1481. 
32. Volova TG, Shishatskaya EI, Nikolaeva ED, Sinskey AJ. In vivo study of 2D PHA matrices 
of different chemical compositions: tissue reactions and biodegradations. Mater Sci Technol. 
2014;30:549-557. 
33. Saad B, Hirt TD, Welti M, Uhlschmid GK, Neuenschwander P, Suter UW. Development of 
degradable polyesterurerethans for medical applications: in vitro and in vivo evaluations. J 
Biomed Mater Res. 1997;36;65–74. 
34. Tezcaner A, Bugra K, Hasirci V. Retinal pigment epithelium cell culture on surface 
modified poly(hydroxybutyrate-co-hydroxyvalerate) thin films. Biomaterials 2003;24:4573–
4583. 
35. Liu P, Deng Z, Han S, Liu T, Wen N, Lu W, Geng X, Huang S, Jin Y. Tissue-Engineered 
Skin Containing Mesenchymal Stem Cells Improves Burn Wounds. Artif Organs 2008;32:925–
931. 
36. Lucchesi C, Ferreira BMP, Duek EAR, Santos Jr. AR, Joazeiro PP. Increased response of 
Vero cells to PHBV matrices treated by plasma. J Mater Sci-Mater M.2008;19:635-643. 
37. Köse GT, Kokusuz F, Özkul A, Soysal Y, Ozdemir T, Yildiz C, Hasirci V. Tissue 
engineered cartilage on collagen and PHBV matrices. Biomaterials 2005;26:5187–5197. 
38. Qu XH, Wu Q, Liang J, Qu X, Wang SG, Chen GQ. Enhanced vascular-related cellular 
affinity on surface modified copolyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate 
(PHBHHx) Biomaterials 2005;26:6991–7001. 
39. Rentsch C, Rentsch B, Breier A, Hofmann A, Manthey S, Scharnweber D, Biewener A and 
Zwipp H. Evaluation of the osteogenic potential and vascularization of 3D 
poly(3)hydroxybutyrate scaffolds subcutaneously implanted in nude rats. J Biomed Mater Res A. 
2010;92:185–195. 
40. Wang L,WangZH,ShenCY,You ML, Xiao JF,Chen GQ. Differentiation of human bone 
marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into 
nerve cells. Biomaterials 2010;31:1691-1698. 
41. You M, Peng G, Li J, Ma P, Wang Z, Shu W, Peng S, Chen GQ. Chondrogenic 
differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) 
scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials 
2011;32:2305-2313. 
42. Ji Y, Li XT, Chen GQ. Interactions between a poly(3-hydroxybutyrate-co-3-
hydroxyvalerate-co-3-hydroxyhexanoate) terpolyester and human keratinocytes. Biomaterials 
2008;29:3807–3814. 
43.         Volova TG, Kiselev EG, Shishatskaya EI, Zhila NO, Boyandin AN, Syrvacheva DA, 
Vinogradova ON, Kalacheva GS, Vasiliev AD, Peterson IV. Cell growth and accumulation of 
polyhydroxyalkanoates from CO2 and H2 of a hydrogen-oxidizing bacterium, 
Cupriaviduseutrophus B-10646. Bioresour Technol. 2013;146:215-222. 
44. Volova TG and Shishatskaya EI. RF Patent No. 2439143. 
45. Volova T, Goncharov D, Sukovatyi A, Shabanov A, Nikolaeva E, Shishatskaya E. 
Electrospinning of polyhydroxyalkanoate fibrous scaffolds: effects on electrospinning 
parameters on structure and properties. J BiomaterSciPolym Ed. 2014;25:370-93. 
46. Kaelble DH. Dispersion-polar surface tension properties of organic solids. J Adhes. 
1970;2:66–81. 
47. Jelvani S, Pazokian H, MoradiFarisar S. Effect of CO2pulsed laser irradiation on improving 
the biocompatibility of a polyethersulfone film. J Phys: Conference Ser. 2013;414:012021. 
48. Kang YO, Yoon IS, Lee SY, Kim DD, Lee SJ, Park WH, Hudson SM. Chitosan-coated 
poly(vinyl alcohol) nanofibers for wound dressings. J Biomed Mater Res B ApplBiomater. 
2010;92:568-76. 
49. Franco RA, Min YK, Yang HM, Lee BT. Fabrication and biocompatibility of novel bilayer 
scaffold for skin tissue engineering applications. J Biomater Appl. 2013;27:605-615. 
50. Jin G, Prabhakaran MP, Kai D, Sathesh KA, Arunachalam KD, Ramakrishna S. Tissue 
engineered plant extracts as nanofibrous wound dressing. Biomaterials 2013;34:724-734. 
51. Pezeshki-Modaress M, Mirzadeh H, Zandi M. Gelatin-gag electrospunnanofibrous scaffold 
for skin tissue engineering: Fabrication and modeling of process parameters. Mater SciEng 
C.2015;48:704–712. 
52.        Blackwood KA, McKean R, Canton I, Freeman CO, Franklin KL, Cole D, Brook I, Farthing 
P, Rimmer S, Haycock JW, Ryan AJ, MacNeil S. Development of biodegradable electrospun 
scaffolds for dermal replacement. Biomaterials 2008;29:3091–3104. 
53. Shishatskaya EI, Volova TG, Gordeev SA, Puzyr AP. Degradation of P(3HB) and P(3HB-
co-3HV) in biological media. J BiomaterSci Polymer Ed. 2005;16:643-657. 
54. Li X-T, Zhang Y, Chen G-Q. Nanofibrouspolyhydroxyalkanoate matrices as cell growth 
supporting materials. Biomaterials 2008;29:3720–3728. 
55. Sombatmankhong K, Sanchavanakit N, Pavasant P, Supaphol P. Bone scaffolds from 
electrospun fiber mats of poly(3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) and their blend. Polymer 2007;48:1419-1427. 
56. Kim Y-J,Bae H-I, Kwon OK, Choi M-S. Three-dimensional gastric cancer cell culture using 
nanofiber scaffold for chemosensitivity test. Int J BiolMacromol. 2009;45:65–71. 
57.        Zhou J, Peng S-W, Wang Y-Y, Zheng S-B, Wang Y, Chen G-Q. The use of poly(3-
hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds for tarsal repair in eyelid reconstruction in 
the rat. Biomaterials 2010;31:7512-7518. 
58.        Murueva AV, Shershneva AM, Shishatskaya EI, Volova TG. The Use of Polymeric 
Microcarriers Loaded with Anti-Inflammatory Substances in the Therapy of Experimental Skin 
Wounds. Bull ExpBiol Med, Pharmacology and toxicology 2014;157:597-602. 
59. Potapov IV, Il’inskii OM, Kurenkova LG, Sevast’yanov VI, Egorova VA, Zaidenov VA, 
Rasulov MF, Onishchenko NA. ElastoPHB® Membrane Systems with Immobilized Bone 
Marrow Stromal Cells Optimize Conditions for Regeneration of Damaged Tissue. Cell 
TechnolBiol Med 2005;3:132-137 (in Russian). 
60. Volova TG, Sevastianov VI, Shishatskaya EI. Matrix of polyhydroxyalkanoates for cell and 
tissue engineering. In: Shumakov VI, editor. Polyhydroxyalkanoates – Biodegradable Polymers 
for Medicine. Krasnoyarsk: Platinum; 2006. pp. 209-216 (in Russian). 
